Rare Hemophilia Factors Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

By Treatment (Factor Concentrates, Fresh Frozen Plasma, Cryoprecipitate, Others), By Type (Factor I, Factor II, Factor V, Factor VII, Factor X, Factor XI, Factor XIII) Region and Competition

Published	Pages	Publisher	Report code
Jan 2024	182	TechSci Research	ASDR-656835

Published: Jan 2024 - Pages : 182 - Publisher : TechSci Research - Report code : ASDR-656835

1. Novo Nordisk
2. Biogen
3. Bayer AG
4. Pfizer Inc.
5. Shire Pharmaceuticals
6. Baxalta (Baxter Healthcare)
7. CSL Behring
8. Bio Products Laboratory Ltd.

Specialty Drug Distribution Market - Global Forecast 2024-2030

This report can be of interest as well:

Specialty Drug Distribution Market - Global Forecast 2024-2030

Published: April, 2024 | Report code: ASDR-664429